Tue, October 6, 2015
Mon, October 5, 2015
Fri, October 2, 2015
Thu, October 1, 2015
Wed, September 30, 2015
Tue, September 29, 2015
Mon, September 28, 2015
Fri, September 25, 2015
Thu, September 24, 2015
Wed, September 23, 2015
Tue, September 22, 2015
Mon, September 21, 2015
Fri, September 18, 2015
Thu, September 17, 2015
Wed, September 16, 2015
Tue, September 15, 2015
Mon, September 14, 2015
Fri, September 11, 2015
Thu, September 10, 2015
Wed, September 9, 2015
Tue, September 8, 2015
Mon, September 7, 2015
Fri, September 4, 2015
Thu, September 3, 2015
Wed, September 2, 2015
Tue, September 1, 2015
Mon, August 31, 2015
Sat, August 29, 2015
Fri, August 28, 2015
Thu, August 27, 2015
Wed, August 26, 2015
Tue, August 25, 2015
Mon, August 24, 2015
Fri, August 21, 2015
Thu, August 20, 2015
Wed, August 19, 2015
Tue, August 18, 2015
Mon, August 17, 2015
Fri, August 14, 2015
Thu, August 13, 2015
Wed, August 12, 2015
Tue, August 11, 2015
Mon, August 10, 2015
Fri, August 7, 2015

Matthew Harrison Initiated (BLUE) at Hold and Held Target at $143 on, Sep 8th, 2015


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. hold-and-held-target-at-143-on-sep-8th-2015.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Harrison of Morgan Stanley, Initiated "bluebird bio, Inc." (BLUE) at Hold and Held Target at $143 on, Sep 8th, 2015.

Matthew has made no other calls on BLUE in the last 4 months.



There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Matthew


  • Jason McCarthy of "Maxim Group" Maintained at Strong Buy and Held Target at $190 on, Wednesday, June 17th, 2015
  • Matthew Luchini of "BMO Capital" Maintained at Buy with Increased Target to $239 on, Monday, June 15th, 2015
  • Cory Kasimov of "JP Morgan" Maintained at Buy with Increased Target to $244 on, Monday, June 15th, 2015

Publication Contributing Sources